RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.

MLA

Cáceres-Gorriti, Katia Y., et al. “RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer.” PloS One, vol. 9, no. 3, Mar. 2014, p. e91000. EBSCOhost, https://doi.org/10.1371/journal.pone.0091000.

APA

Cáceres-Gorriti, K. Y., Carmona, E., Barrès, V., Rahimi, K., Létourneau, I. J., Tonin, P. N., Provencher, D., & Mes-Masson, A.-M. (2014). RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer. PloS One, 9(3), e91000. https://doi.org/10.1371/journal.pone.0091000

Chicago

Cáceres-Gorriti, Katia Y, Euridice Carmona, Véronique Barrès, Kurosh Rahimi, Isabelle J Létourneau, Patricia N Tonin, Diane Provencher, and Anne-Marie Mes-Masson. 2014. “RAN Nucleo-Cytoplasmic Transport and Mitotic Spindle Assembly Partners XPO7 and TPX2 Are New Prognostic Biomarkers in Serous Epithelial Ovarian Cancer.” PloS One 9 (3): e91000. doi:10.1371/journal.pone.0091000.